WELCOME TO A PLACE THAT’S FULL OF LIFE.

As soon as you arrive here, you’ll feel it. This is a growing place with big plans – more than £10 billion of investment underway. New developments across the region are attracting international healthcare businesses to locate here alongside our growing local successful companies.

Health and Life Sciences companies that share our passion for research and discovery will be impressed by the quality and quantity of world-class R&D that is conducted here. Our schools, colleges and universities are working alongside big pharma and start-ups to build an exceptional talent pool.


WE ARE INVESTING BILLIONS.

We are investing billions of pounds in our health ecosystem that offers countless opportunities from research, drug discovery, and clinical trials through to biomanufacturing.

The unique convergence of major assets in science, technology, manufacturing and digital innovation is creating a melting pot of ideas and ground breaking solutions.

Our global leadership in health and life sciences is driving innovation in specialist areas such as: Infection, Precision Medicine, Children’s Health, Veterinary Science, Healthy and Independent Living, Big Data, Sensors and Internet of Things.

With hundreds of medical companies based here, the area is part of the Liverpool-Manchester life sciences corridor, which is considered to be one of the UK’s top three clusters of biomedical activity.

The new £429 million Royal Liverpool Hospital is our iconic, flagship development that will transform healthcare in the city region. The 12-storey building, due to open 2017/18 and will have 650 beds, 18 state-of-the-art theatres, 23 wards and units, and includes a large clinical research facility. The new hospital will also have a comprehensive cancer centre on site working in collaboration with Clatterbridge Cancer Centre NHS Foundation Trust.

There are already over £1 billion of new developments underway in KQ Liverpool, including a new £25 million Life Sciences Accelerator, the £15 million Sensor City initiative and the £68 million Materials Innovation Factory where Unilever and the University of Liverpool are collaborating to create innovative products and materials.

Our world-famous Alder Hey Children’s Hospital moved to its new home in 2015 and today treats 270,000 children, young people and their families. Alder Hey leads research into children’s medicines, infection, inflammation and oncology and is a Centre of Excellence for cancer, muscular dystrophy, spinal, heart and brain conditions. It has Europe’s first intra-operative 3-T MRI scanner which is a pioneering technology for neurosurgery.

WE ARE CHALLENGERS.

We are pioneers in healthcare research and development. Some of the world’s smartest people are working alongside global companies to push the boundaries of medical knowledge. The University of Liverpool has been at the forefront of world-shaping research for 130 years and the Health and Life Sciences Faculty has globally renowned institutes specialising in:

• Ageing and Chronic Disease
• Clinical Sciences
• Infection and Global Health
• Integrative Biology
• Life and Human Sciences
• Psychology, Health and Society
• Translational Medicine
• Veterinary Science

Liverpool has Centres of Excellence that facilitate powerful, productive collaborations between university academics and industry experts from around the world. These include several National Institutes for Health Research (NIHR) and Medical Research Council (MRC) centre.

Liverpool John Moores University (LJMU) also has research institutes specialising in Sport and Exercise Sciences, Public Health, and Brain and Behaviour. Research specialities at LJMU include Innovation in Dementia, Chemoinformatics, Nutrition, Nursing and Social Work research.

The Liverpool School of Tropical Medicine (LSTM) is one of the world’s most important centres in the fight against malaria and other insect-borne diseases. Research at the newly-built Centre for Infectious Diseases is funded by the Bill & Melinda Gates Foundation which was extended for another five years in 2016 when the Microsoft founder visited Liverpool.

 

THE SCALE AND DIVERSITY FOR CLINICAL TRIALS.

Novartis

We’re perfectly positioned as a location for medical research and trials. With around seven million people and a diverse ethnic mix, the North West of England enjoys clinical trial recruitment rates second to none in the UK. Our world-class research hospitals work alongside industry expertise offering the ability to address all stages of clinical trials.

Our hospitals are currently running more than 450 research studies and trials, many relating to cancer. Major pan-European studies have been led from here and the area has a broad portfolio of clinical cancer trials, with a particular emphasis on pancreas, liver, biliary, uveal, haematological, breast and urothelial malignancies.

Clinical areas that are brought together in specialised trials units include paediatrics, pharmacogenetics, neuroscience, ophthalmology and infection.

A centre-piece of our clinical trials credentials is the Royal Liverpool Clinical Research Unit (CRU), a resource which is open to researchers from all disciplines encouraging collaboration with investigators in Liverpool City Region and beyond. The CRU has become the first NHS facility in England to be granted Medicines and Healthcare Products Regulatory Agency (MHRA) standard and supplementary Phase I Accreditation.

MHRA Phase I Accreditation allows the Trust to perform clinical trials in patients with some of the newest treatments under evaluation, to some of the most rigorous set of standards in the world.

It will help provide patients with greater access to the very latest drugs and technologies and will bring economic benefits to Liverpool City Region as a centre for global healthcare research.

Patient studies are supported by the University of Liverpool through the Liverpool Clinical Trials Collaborative, which receives National Institute for Health Research funding for the Cancer Research UK Liverpool Cancer Trials Unit and the Clinical Trials Research Centre.

 

WE ARE CREATORS.

Liverpool is a place for creators and makers. From the creative sparks imagining new materials and processes, to the geniuses designing cars and ships. From the innovators making solar panels and wind turbines, to the chemists discovering new drugs and the scientists rolling back frontiers.

Given the strength of our life sciences credentials and manufacturing pedigree, it shouldn’t be a surprise that we’re home to one of Europe’s largest concentrations of biomanufacturing. Major pharma players include AstraZeneca, Baxter Healthcare, Bristol Myers Squibb, Eli Lilly, Nestle Health Science, Seqirus and Unilever, all have facilities in the area.

Significant new investments in modern production facilities at these companies have created a vibrant, efficient and cost-competitive environment to produce new drugs and vaccines.

Locating a production facility in Liverpool City Region delivers a competitive edge with the cost of property being a fraction of the cost found in other life sciences clusters.

WE ARE COLLABORATORS.

This is a friendly and open place. People here work best when they work together. For us, networking is a way of life. Our sense of community and solidarity runs deep. We attract talent and business from around the world and bring them together in collaborative networks and shared spaces to create a special alchemy.

life sci coverFor more information on Health and Life Sciences in Liverpool City Region, download the brochure here.